MedTrace Logo

Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data

NCT07525167 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2026-07-09

No results posted yet for this study

Summary

Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data from the First Three Postnatal Weeks with Large Language Models: A Retrospective Study This retrospective, observational study aims to evaluate the early prediction of bronchopulmonary dysplasia (BPD) in preterm infants using clinical data from the first, second, and third postnatal weeks. The study includes infants born before 32 weeks of gestation or weighing less than 1,500 grams, followed at the Neonatal Intensive Care Unit of Konya City Hospital.

The study will compare the performance of different large language models (LLMs), including ChatGPT, Gemini, and Claude, in predicting BPD development. Clinical variables such as gestational age, birth weight, respiratory support, oxygen requirement, mechanical ventilation duration, and infection status will be used.

Primary outcome: Accuracy of BPD risk prediction by each AI model compared to actual clinical outcomes. Secondary outcomes: Sensitivity and specificity of predictions, weekly prediction performance, and comparative performance among AI models.

The results will provide insight into the potential clinical utility of AI-based approaches for early BPD risk assessment in preterm infants.

Conditions

  • Bronchopulmonary Dysplasia

Interventions

OTHER

Artificial Intelligence-Based Risk Prediction

Different large language models (ChatGPT, Gemini, Claude) will analyze retrospective clinical data to predict the risk of bronchopulmonary dysplasia (BPD). This is an observational evaluation; no experimental treatment or therapy is administered.

Sponsors & Collaborators

  • Konya City Hospital

    lead OTHER

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2026-12-01
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07525167 on ClinicalTrials.gov